Back to MW Marshall Wace, LLP

ANROANRO

Showing 7 of 9 quarters

Position history for MWMarshall Wace, LLP's holdings in Alto Neuroscience, Inc.

Yes. Marshall Wace holds 225,503 shares of ANRO (Alto Neuroscience), worth $6M, as of its Q2 2026 13F filing. It increased the position by 49,156 shares (+27.9%) from Q1 2026. Marshall Wace has held ANRO since Q4 2024, across 7 quarterly 13F filings.

Current Value

$6M

Current Shares

225,503

Total Value Change

+$2.4M

Total Shares Change

-611,871

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
225,503
+27.9%
$6M0.0%$26.39
34
2026-Q1
Decreased
176,347
-8.7%
$4M0.0%$22.48
0
2025-Q4
Decreased
193,109
-76.6%
$3.4M0.0%$17.80
0
2025-Q3
Decreased
825,225
-12.0%
$3.3M0.0%$4.02
0
2025-Q2
Increased
937,407
+9.9%
$2.1M0.0%$2.20
29
2025-Q1
Increased
852,990
+1.9%
$1.8M0.0%$2.16
26
2024-Q4
New
837,374
—
$3.5M0.0%$4.23
37

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used